SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2 )*
Ansan, Inc
(Name of Issuer)
Common Stock, $.001 par value
(Title of Class of Securities)
036338
(CUSIP Number)
Check the following box if a fee is being paid with this statement |_|. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 4 Pages
<PAGE>
- ----------------- -----------------
CUSIP No. 036338 13G Page 2 of 4 Pages
- ----------------- -----------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON Titan Pharmaceuticals, Inc.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 94-3171940
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
---------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
---------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
---------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
SEC 174__ (6-__) * SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Page 3 of 4 Pages
Item 1(a). Name of Issuer :
Ansan, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
400 Oyster Point Boulevard
Suite 435
San Francisco, CA 94080
Item 2(a). Name of Person Filing:
See item 1 on page 2
Item 2(b). Address of Principal Business Office or if none, Residence:
See item 1(b) above
Item 2(c). Citizenship:
See item 4 on page 2
Item 2(d). Title of Class of Securities:
Common Stock, $.001 par value
Item 2(e). CUSIP Number:
036338
Item 3. Not Applicable
Item 4. Ownership
Not Applicable
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [ X ]
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not Applicable
<PAGE>
Item 7. Identification and Classification of Subsidiary Which Acquired
the Securities
Not Applicable
Item 8. Identification and Classification of Members of the Group
Not Applicable
Item 9. Notice of Dissolution of Group
Not Applicable
Item 10. Certification
Not Applicable
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
December 11, 1997
Titan Pharmaceuticals, Inc.
By: /s/Sunil Bhonsle
---------------------------------------
Sunil Bhonsle, Executive Vice President
